IMO, more important than financials, except for guidance as to funds needed for the next 12-18 months, is what guidance they give on trial time lines, enrollment expectations, interfacing with FDA etc. If it is only about the financials then a 15%+ drop becomes greater than 50/50 odds. NDA's if any would be a positive as well. Any news about funding from Australian Gov or health system.
Be interested what the other AVXL'ers that frequent here think.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.